For other countries, any question or an interest in distributing OncoDEEP in your country please contact us at email@example.com
The unique personalized non-invasive blood based solution to monitor the evolution of the tumor and the effectiveness of the treatment.
During the development and/or the death of cancer cells, some small fragments of nucleic acids that are not associated with cells or cell fragments are released into the blood. Those DNA fragments are called cell-free circulating DNA (ctDNA).
ctDNA is released by both the primary tumor and metastases, so that its analysis gives a comprehensive and consistent image that reflects the whole genetic landscape of a patient's cancer. ctDNA not only contains the mutations already present in the primary tumor site but also those present in (and perhaps responsible for) metastases.
OncoTRACE is the first & unique solution to monitor the evolution of the disease without any invasive biopsy. It consists in three steps:
This new and unique approach for cancer monitoring and treatment responses follow-up shows several benefits:
NB: This solution is only available for any stage III or IV metastatic solid tumor in adults.
OncoDNA provides multiples solutions for the right cancer approach and cancer treatment
The Most Complete Molecular Profiling Solution to Deliver the Best Treatment Plan for the patient.Learn more
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.